OLP-1002 is Being Studied in the Treatment of Pain.

NCT03760913 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

116

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain

Interventions

DRUG: OLP-1002 (Test): Part A, Single Ascending Dose
DRUG: OLP-1002 (Test): Part B, Multiple Ascending Dose
OTHER: Placebo: Placebo Part A, Single Ascending Dose
OTHER: Placebo: Placebo Part B, Multiple Ascending Dose

Sponsor

OliPass Corporation